Search
Journey Medical Corp
DERMAdd to Watchlist
4.390USD
-0.050-1.13%
Close 11-11 16:00（ET）
97.55MMarket Cap
LossP/E TTM
Journey Medical Corp (DERM) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Journey Medical Corp in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
13.750USD+165.96%
DERM Analyst Recommendation Trends
In the current month, DERM has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DERM average Analyst price target in the last month is 13.750.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
DERM Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, DERM EPS is projected to reach -0.010 in FY2026Q3, following reported EPS of -0.011 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.06
-0.08
-0.02
-0.01
-0.00
Actual
-0.05
-0.08
-0.01
--
--
Surprise
+19.98%
-5.38%
+49.56%
--
--
FAQs
What is Journey Medical Corp's expected revenue for the next quarter?
Journey Medical Corp's expected revenue is 20.32M.
What is Journey Medical Corp's price target?
Analysts forecast that Journey Medical Corp's price target is USD 13.75, with the highest forecast at USD 15.00 and the lowest forecast at USD 13.00.
How have Journey Medical CorpDERM's recent earnings per share performed?
The market expectation was USD -0.01, while Journey Medical CorpDERM's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.01.
What is the analyst rating for Journey Medical Corp?
Based on the ratings of Journey Medical Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.